{"archive_url":"http://www.ebi.ac.uk/ena/data/view/ERX297409","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"ERX297409","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["3x 10 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 µl"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 µg"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 µl"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"ENA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"999K","NAME":"BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.bb","FILE_TYPE":"CS_MACS_TRACK_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.bb","PROTOCOL_DOC":"chip_seq","MD5":"ec43b922075dce85a7b895ea20f5b16b"},{"FORMAT":"BED","SIZE":"1.2M","NAME":"BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.bed.gz","FILE_TYPE":"CS_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.bed.gz","PROTOCOL_DOC":"chip_seq","MD5":"8973d73b4fc2bd8e7e17e7820275d62a"},{"FORMAT":"Text","SIZE":"1.3M","NAME":"BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.xls.gz","FILE_TYPE":"CS_MACS2","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K4me3.ppqt_macs2_v2.20130819.xls.gz","PROTOCOL_DOC":"chip_seq","MD5":"73daab3cb96df763f7cf93303ac7b99e"},{"FORMAT":"bigWig","SIZE":"971M","NAME":"BP_Z-138_c01.H3K4me3.wiggler.20130819.bw","FILE_TYPE":"CS_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K4me3.wiggler.20130819.bw","PROTOCOL_DOC":"chip_seq","MD5":"322d8f37fdd230c7106825d08d24ade1"}],"sample":{"SAMPLE_SOURCE":"Cell Line","SAMPLE_NAME":"Z-138","sample_barcode":"Z-138_c01","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"MOLECULE":["genomic DNA"],"DISEASE":["Mantle cell lymphoma"],"BIOMATERIAL_PROVIDER":["WP4_Bergmann_Siebert_Martin-Subero"],"BATCH":["NA"],"LINEAGE":["NA"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C2853894","label":"C2853894"}],"SAMPLE_ONTOLOGY_URI":[{"url":"http://www.ebi.ac.uk/efo/EFO_0005479","label":"EFO_0005479"}],"PASSAGE":["NA"],"SEX":["Male"],"DIFFERENTIATION_STAGE":["B cell"],"MEDIUM":["RPMI 1640 + 10%FBS"],"LINE":["Z-138"]},"SAMPLE_ID":"ERS333896","SAMPLE_DESCRIPTION":"Mantle cell lymphoma"}}